{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T06:05:27Z","timestamp":1783749927662,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002480"],"award-info":[{"award-number":["82002480"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>Ganoderma lucidum<\/jats:italic> is reportedly the best source of traditional natural bioactive constituents. Ganoderma triterpenoids (GTs) have been verified as an alternative adjuvant for treating leukemia, cancer, hepatitis and diabetes. One of the major triterpenoids, Resinacein S, has been found to regulate lipid metabolism and mitochondrial biogenesis. Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease that has become a major public health problem. Given the regulatory effects on lipid metabolism of Resinacein S, we sought to explore potential protective effects against NAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Resinacein S was extracted and isolated from G. <jats:italic>lucidum<\/jats:italic>. And mice were fed with high fat diet with or without Resinacein S to detect hepatic steatosis. According to Network Pharmacology and RNA-seq, we analyzed the hub genes of Resinacein S against NAFLD disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our results can be summarized as follows: (1) The structure of Resinacein S was elucidated using NMR and MS methods. (2) Resinacein S treatment could significantly attenuate high-fat diet (HFD)-induced hepatic steatosis and hepatic lipid accumulation in mouse. (3) GO terms, KEGG pathways and the PPI network of Resinacein S induced Differentially Expressed Genes (DEGs) demonstrated the key target genes of Resinacein S against NAFLD. (4) The hub proteins in PPI network analysis could be used for NAFLD diagnosis and treatment as drug targets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Resinacein S can significantly change the lipid metabolism in liver cells and yield a protective effect against steatosis and liver injury. Intersected proteins between NAFLD related genes and Resinacein S-induced DEGs, especially the hub protein in PPI network analysis, can be used to characterize targets of Resinacein S against NAFLD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2023.1076569","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T17:34:26Z","timestamp":1676396066000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism"],"prefix":"10.3389","volume":"10","author":[{"given":"Fei-Fei","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Kai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Yun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Qun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"key":"ref1","first-page":"792","article-title":"Ganoderma lucidum (Reishi mushroom) and cancer","volume":"21","author":"Unlu","year":"2016","journal-title":"J BUON"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1002\/ptr.7215","article-title":"Ganoderma lucidum (Reishi) an edible mushroom; a comprehensive and critical review of its nutritional, cosmeceutical, mycochemical, pharmacological, clinical, and toxicological properties","volume":"35","author":"Ahmad","year":"2021","journal-title":"Phytother Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1615\/IntJMedMushrooms.2017024537","article-title":"The efficacy and toxicity of using the Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (Agaricomycetes), and its products in chemotherapy (review)","volume":"19","author":"Cizmarikova","year":"2017","journal-title":"Int J Med Mushrooms"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2174\/138920109789978757","article-title":"Ganoderma lucidum: a potent pharmacological macrofungus","volume":"10","author":"Sanodiya","year":"2009","journal-title":"Curr Pharm Biotechnol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/10286020600979910","article-title":"Two new Lanostanoids from Ganoderma resinaceum","volume":"9","author":"Niu","year":"2007","journal-title":"J Asian Nat Prod Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"109303","DOI":"10.1016\/j.foodres.2020.109303","article-title":"Triterpenoids from functional mushroom Ganoderma resinaceum and the novel role of Resinacein S in enhancing the activity of Brown\/beige adipocytes","volume":"136","author":"Huang","year":"2020","journal-title":"Food Res Int"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Front Biosci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"983450","DOI":"10.3389\/fnut.2022.983450","article-title":"Corilagin prevents non-alcoholic fatty liver disease via improving lipid metabolism and glucose homeostasis in high fat diet-fed mice","volume":"9","author":"Liao","year":"2022","journal-title":"Front Nutr"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","article-title":"Pathophysiology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"22","author":"Manne","year":"2018","journal-title":"Clin Liver Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e11272","DOI":"10.7717\/peerj.11272","article-title":"Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis","volume":"9","author":"Sui","year":"2021","journal-title":"PeerJ"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4314\/ajtcam.v8i3.65289","article-title":"Medicinal uses of mushrooms in Nigeria: towards full and sustainable exploitation","volume":"8","author":"Oyetayo","year":"2011","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s12072-021-10138-1","article-title":"Gut-liver Axis modulation of Panax Notoginseng Saponins in nonalcoholic fatty liver disease","volume":"15","author":"Xu","year":"2021","journal-title":"Hepatol Int"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbacli.2014.09.001","article-title":"Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients","volume":"3","author":"Goh","year":"2015","journal-title":"BBA Clin"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1210\/jc.2018-01171","article-title":"Ghrelin reduces TNF-alpha-induced human hepatocyte apoptosis, autophagy, and pyroptosis: role in obesity-associated NAFLD","volume":"104","author":"Ezquerro","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.orcp.2016.03.009","article-title":"Body mass index and the visceral adipose tissue expression of Il-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity","volume":"12","author":"Jorge","year":"2018","journal-title":"Obes Res Clin Pract"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/ddr.21905","article-title":"Schisandrin B ameliorates non-alcoholic liver disease through anti-inflammation activation in diabetic mice","volume":"83","author":"Ma","year":"2022","journal-title":"Drug Dev Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13040-020-00224-9","article-title":"Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease","volume":"13","author":"Hu","year":"2020","journal-title":"BioData Min"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejphar.2018.02.035","article-title":"Berberine induces miR-373 expression in hepatocytes to inactivate hepatic steatosis associated AKT-S6 kinase pathway","volume":"825","author":"Li","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.bbadis.2018.12.014","article-title":"Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y gastric bypass in mice","volume":"1865","author":"Pan","year":"2019","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/liv.12600","article-title":"Reduced hepatic lipid content in Pten-Haplodeficient mice because of enhanced AKT2\/PKBbeta activation in skeletal muscle","volume":"35","author":"Schultze","year":"2015","journal-title":"Liver Int"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13069-016-0045-1","article-title":"Activation of hepatic stellate cell in Pten null liver injury model","volume":"9","author":"He","year":"2016","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.cell.2020.05.053","article-title":"Metabolic fingerprinting links oncogenic Pik3ca with enhanced arachidonic acid-derived eicosanoids","volume":"181","author":"Koundouros","year":"2020","journal-title":"Cells"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/onc.2015.179","article-title":"Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP","volume":"35","author":"Ricoult","year":"2016","journal-title":"Oncogene"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"14544","DOI":"10.1021\/acs.jafc.1c05400","article-title":"Estrogen receptor alpha regulates metabolic-associated fatty liver disease by targeting NLRP3-GSDMD axis-mediated hepatocyte pyroptosis","volume":"69","author":"Gao","year":"2021","journal-title":"J Agric Food Chem"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","volume":"1043","author":"Palmisano","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.steroids.2017.10.015","article-title":"Estrogens and female liver health","volume":"133","author":"Chen","year":"2018","journal-title":"Steroids"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1124\/dmd.115.065979","article-title":"CYP3A activity and expression in nonalcoholic fatty liver disease","volume":"43","author":"Woolsey","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1124\/mol.116.104687","article-title":"A fibroblast growth factor 21-Pregnane X receptor pathway downregulates hepatic CYP3A4 in nonalcoholic fatty liver disease","volume":"90","author":"Woolsey","year":"2016","journal-title":"Mol Pharmacol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/hep.22063","article-title":"Low circulating levels of Dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease","volume":"47","author":"Charlton","year":"2008","journal-title":"Hepatology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"102187","DOI":"10.1016\/j.redox.2021.102187","article-title":"The sex steroid precursor Dehydroepiandrosterone prevents nonalcoholic steatohepatitis by activating the AMPK pathway mediated by GPR30","volume":"48","author":"Li","year":"2021","journal-title":"Redox Biol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1016\/j.celrep.2016.11.048","article-title":"Dual Shp2 and Pten deficiencies promote non-alcoholic steatohepatitis and genesis of liver tumor-initiating cells","volume":"17","author":"Luo","year":"2016","journal-title":"Cell Rep"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1076569\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T17:34:30Z","timestamp":1676396070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1076569\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":33,"alternative-id":["10.3389\/fnut.2023.1076569"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2023.1076569","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,14]]},"article-number":"1076569"}}